Michael Thomas (M Thomas)

ORCID

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 19

Top Venues

International journal of cancer

Cancers

International journal of molecular sciences

Pneumologie (Stuttgart, Germany)

This page only lists publications with an associated author ORCID identifier.

Publications

Martin Sebastian, Wilfried E E Eberhardt, Eyck von der Heyde, Steffen Dörfel, Jörg Wiegand, Clemens Schiefer, Christoph Losem, Martina Jänicke, Annette Fleitz, Stefan Zacharias, Anja Kaiser-Osterhues, Annette Hipper, Corinna Dietel, Annalen Bleckmann, Robin Benkelmann, Michael Boesche, Christian Grah, Annette Müller, Frank Griesinger, Michael Thomas, null null
Patient-reported outcomes in advanced NSCLC before and during the COVID-19 pandemic: Real-world data from the German prospective CRISP Registry (AIO-TRK-0315). International journal of cancer 154 (11) (2024)
Bilal Alashkar Alhamwe, Kadriya Yuskaeva, Friederike Wulf, Frederik Trinkmann, Mark Kriegsmann, Michael Thomas, Corinna Ulrike Keber, Elke Pogge von Strandmann, Felix J Herth, Saeed Kolahian, Harald Renz, Thomas Muley
Peripheral Inflammation Featuring Eosinophilia or Neutrophilia Is Associated with the Survival and Infiltration of Eosinophils within the Tumor among Various Histological Subgroups of Patients with NSCLC. International journal of molecular sciences 25 (17) (2024)
Martin Sebastian, Wilfried E E Eberhardt, Eyck von der Heyde, Steffen Dörfel, Jörg Wiegand, Clemens Schiefer, Christoph Losem, Martina Jänicke, Annette Fleitz, Stefan Zacharias, Anja Kaiser-Osterhues, Annette Hipper, Corinna Dietel, Annalen Bleckmann, Robin Benkelmann, Michael Boesche, Christian Grah, Annette Müller, Frank Griesinger, Michael Thomas, null null
Patient-reported outcomes in advanced NSCLC before and during the COVID-19 pandemic: Real-world data from the German prospective CRISP Registry (AIO-TRK-0315). International journal of cancer (2024)
Martin Sebastian, Wilfried E E Eberhardt, Eyck von der Heyde, Steffen Dörfel, Jörg Wiegand, Clemens Schiefer, Christoph Losem, Martina Jänicke, Annette Fleitz, Stefan Zacharias, Anja Kaiser-Osterhues, Annette Hipper, Corinna Dietel, Annalen Bleckmann, Robin Benkelmann, Michael Boesche, Christian Grah, Annette Müller, Frank Griesinger, Michael Thomas, null null
Patient-reported outcomes in advanced NSCLC before and during the COVID-19 pandemic: Real-world data from the German prospective CRISP Registry (AIO-TRK-0315). International journal of cancer 154 (11) (2024)
Edward B Garon, Shun Lu, Yasushi Goto, Pedro De Marchi, Luis G Paz-Ares, David R Spigel, Michael Thomas, James Chih-Hsin Yang, Andrea Ardizzoni, Fabrice Barlesi, Sergey V Orlov, Hiroshige Yoshioka, Giannis Mountzios, Sadhvi Khanna, Claudia Bossen, Mariana Carbini, Sabine Turri, Andrea Myers, Byoung Chul Cho
Canakinumab as Adjuvant Therapy in Patients With Completely Resected Non-Small-Cell Lung Cancer: Results From the CANOPY-A Double-Blind, Randomized Clinical Trial. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2023)
Stephanie J Yaung, Corinna Woestmann, Christine Ju, Xiaoju Max Ma, Sandeep Gattam, Yiyong Zhou, Liu Xi, Subrata Pal, Aarthi Balasubramanyam, Nalin Tikoo, Claus Peter Heussel, Michael Thomas, Mark Kriegsmann, Michael Meister, Marc A Schneider, Felix J Herth, Birgit Wehnl, Maximilian Diehn, Ash A Alizadeh, John F Palma, Thomas Muley
Early Assessment of Chemotherapy Response in Advanced Non-Small Cell Lung Cancer with Circulating Tumor DNA. Cancers 14 (10) (2022)
Christian Faltus, Angelika Heissl, Myrto Barrdahl, Yassen Assenov, Anika Hüsing, Olga Bogatyrova, Marina Laplana, Theron Johnson, Thomas Muley, Michael Meister, Arne Warth, Michael Thomas, Christoph Plass, Rudolf Kaaks, Angela Risch
Identification of NHLRC1 as a Novel AKT Activator from a Lung Cancer Epigenome-Wide Association Study (EWAS). International journal of molecular sciences 23 (18) (2022)
Christos Chouaid, Michael Thomas, Didier Debieuvre, Isabelle Durand Zaleski, Stefan Zacharias, Lise Bosquet, Annika Groth, Annette Fleitz, Alan Calleja, Sonya Patel, Laure Lacoin, Melinda J Daumont, John R Penrod, Robert Carroll, Daniela Waldenberger, François-Emery Cotté, Clarisse Audigier-Valette, Frank Griesinger
Effectiveness of Nivolumab in Second-Line and Later in Patients with Advanced Non-Small Cell Lung Cancer in Real-Life Practice in France and Germany: Analysis of the ESME-AMLC and CRISP Cohorts. Cancers 14 (24) (2022)
Christos Chouaid, Michael Thomas, Didier Debieuvre, Isabelle Durand Zaleski, Stefan Zacharias, Lise Bosquet, Annika Groth, Annette Fleitz, Alan Calleja, Sonya Patel, Laure Lacoin, Melinda J Daumont, John R Penrod, Robert Carroll, Daniela Waldenberger, François-Emery Cotté, Clarisse Audigier-Valette, Frank Griesinger
Effectiveness of Nivolumab in Second-Line and Later in Patients with Advanced Non-Small Cell Lung Cancer in Real-Life Practice in France and Germany: Analysis of the ESME-AMLC and CRISP Cohorts. Cancers 14 (24) (2022)
Julia Kunz, Christiane Wiedemann, Heidrun Grosch, Katharina Kriegsmann, Stefanie Gryzik, Julia Felden, Michael Hundemer, Huriye Seker-Cin, Miriam Stenzinger, Albrecht Leo, Albrecht Stenzinger, Michael Thomas, Petros Christopoulos
Early Development of Ubiquitous Acanthocytosis and Extravascular Hemolysis in Lung Cancer Patients Receiving Alectinib. Cancers 14 (11) (2022)
Philip Baum, Samantha Taber, Stella Preussler, Thomas Muley, Mark Kriegsmann, Petros Christopoulos, Michael Thomas, Hauke Winter, Joachim Pfannschmidt, Martin E Eichhorn
Validation of the T Descriptor (TNM-8) in T3N0 Non-Small-Cell Lung Cancer Patients; a Bicentric Cohort Analysis with Arguments for Redefinition. Cancers 13 (8) (2021)
Clemens Aigner, T Brüning, W E E Eberhardt, Martin Härter, H-P Kaelberlah, Martin Metzenmacher, R Shah, Christian Taube, Michael Thomas
[The Current Therapy of Asbestos-Associated Malignant Pleural Mesothelioma - An Expert Consensus Paper]. Pneumologie (Stuttgart, Germany) 75 (10) (2021)
Petros Christopoulos, Farastuk Bozorgmehr, Lena Brückner, Inn Chung, Johannes Krisam, Marc A Schneider, Albrecht Stenzinger, Regina Eickhoff, Daniel W Mueller, Michael Thomas
Brigatinib versus other second-generation ALK inhibitors as initial treatment of anaplastic lymphoma kinase positive non-small cell lung cancer with deep phenotyping: study protocol of the ABP trial. BMC cancer 21 (1) (2021)
David Brunn, Kati Turkowski, Stefan Günther, Andreas Weigert, Thomas Muley, Mark Kriegsmann, Hauke Winter, Reinhard H Dammann, Georgios T Stathopoulos, Michael Thomas, Andreas Guenther, Friedrich Grimminger, Soni Savai Pullamsetti, Werner Seeger, Soni Savai Pullamsetti
Interferon Regulatory Factor 9 Promotes Lung Cancer Progression via Regulation of Versican. Cancers 13 (2) (2021)
Anna-Lena Volckmar, Jonas Leichsenring, Martina Kirchner, Petros Christopoulos, Olaf Neumann, Jan Budczies, Cristiano Manuel Morais de Oliveira, Eugen Rempel, Ivo Buchhalter, Regine Brandt, Michael Allgäuer, Suranand Babu Talla, Moritz von Winterfeld, Esther Herpel, Benjamin Goeppert, Amelie Lier, Hauke Winter, Tilman Brummer, Stefan Fröhling, Martin Faehling, Jürgen R Fischer, Claus Peter Heußel, Felix Herth, Felix Lasitschka, Peter Schirmacher, Michael Thomas, Volker Endris, Roland Penzel, Albrecht Stenzinger
Combined targeted DNA and RNA sequencing of advanced NSCLC in routine molecular diagnostics: Analysis of the first 3,000 Heidelberg cases. International journal of cancer 145 (3) (2019)
Jonas Leichsenring, Peter Horak, Simon Kreutzfeldt, Christoph Heining, Petros Christopoulos, Anna-Lena Volckmar, Olaf Neumann, Martina Kirchner, Carolin Ploeger, Jan Budczies, Christoph E Heilig, Barbara Hutter, Martina Fröhlich, Sebastian Uhrig, Daniel N Kazdal, Michael Allgäuer, Alexander Harms, Eugen Rempel, Ulrich Lehmann, Michael Thomas, Nicole Pfarr, Ninel Azoitei, Irina Bonzheim, Ralf Marienfeld, Peter Möller, Martin Werner, Falko Fend, Melanie Boerries, Nikolas von Bubnoff, Silke Lassmann, Thomas Longerich, Michael Bitzer, Thomas Seufferlein, Nisar Malek, Wilko Weichert, Peter Schirmacher, Roland Penzel, Volker Endris, Benedikt Brors, Frederick Klauschen, Hanno Glimm, Stefan Fröhling, Albrecht Stenzinger
Variant classification in precision oncology. International journal of cancer 145 (11) (2019)
Ivo Buchhalter, Eugen Rempel, Volker Endris, Michael Allgäuer, Olaf Neumann, Anna-Lena Volckmar, Martina Kirchner, Jonas Leichsenring, Amelie Lier, Moritz von Winterfeld, Roland Penzel, Petros Christopoulos, Michael Thomas, Stefan Fröhling, Peter Schirmacher, Jan Budczies, Albrecht Stenzinger
Size matters: Dissecting key parameters for panel-based tumor mutational burden analysis. International journal of cancer 144 (4) (2018)
P Christopoulos, M Kirchner, F Bozorgmehr, Volker Endris, M Elsayed, Jan Budczies, J Ristau, R Penzel, F J Herth, C P Heussel, M Eichhorn, T Muley, M Meister, J R Fischer, S Rieken, F Lasitschka, H Bischoff, R Sotillo, P Schirmacher, Michael Thomas, Albrecht Stenzinger
Identification of a highly lethal V3+ TP53+ subset in ALK+ lung adenocarcinoma. International journal of cancer 144 (1) (2018)
Petros Christopoulos, Volker Endris, Farastuk Bozorgmehr, Mei Elsayed, Martina Kirchner, Jonas Ristau, Ivo Buchhalter, Roland Penzel, Felix J Herth, Claus P Heussel, Martin Eichhorn, Thomas Muley, Michael Meister, Jürgen R Fischer, Stefan Rieken, Arne Warth, Helge Bischoff, Peter Schirmacher, Albrecht Stenzinger, Michael Thomas
EML4-ALK fusion variant V3 is a high-risk feature conferring accelerated metastatic spread, early treatment failure and worse overall survival in ALK+ non-small cell lung cancer. International journal of cancer 142 (12) (2018)

Michael Thomas.css-eqlu8i{font-size:small;padding-left:4px;} (M Thomas)

Publication Activity (10 Years)

Top Topics

Top Venues

Michael Thomas (M Thomas)